PUNE, India, March 7, 2016 /PRNewswire/ --
ReportsnReports.com adds "Investigation Report on China Fluoxetine Market, 2010-2019" and "Global and Chinese Fluoxetine (CAS 54910-89-3) Industry, 2015 Market Research Report" with 2019 and 2020 forecasts data and information to its online business intelligence library.
Complete report on Fluoxetine market spread across 20 pages, covering information on 07 companies and supported with 22 charts is now available at http://www.reportsnreports.com/reports/500794-investigation-report-on-china-fluoxetine-market-2010-2019.html
WHO predicts that by 2020, depression will probably become the second largest disease next to cardio-cerebrovascular disease. Every year, the suicide death toll of depression around the world is up to 1 million people and the amount of depression patients in China has reached 90 million. At present, the recognition rate of depression in our country is only 30% and the identified patients seeking medical advice is also 30%, which means less than 10% of the depressive patients were likely to utilize medical service. Clinical experience shows that 80% of the patients can achieve clinical cure, if having standard treatment, expect very few patients with refractory type, others will be improvement.
Original antidepressants Fluoxetine produced by Eli Lilly and Company was approved for the treatment of depression first in Belgium in 1986. Fluoxetine is a kind of selective serotonin reuptake inhibitors (SSRI) antidepressants and its medicinal form is Fluoxetine hydrochloride. Eli Lilly and Company named their products "the optimal solution" (Prozac) which is used for the treatment of adult depression, obsessive-compulsive disorder and neurological bulimia in clinical practice as well as panic disorder with or without agoraphobe. At the end of 1987, Fluoxetine was approved by the U.S. Food and Drug Administration (FDA) to enter American market, and it entered the Chinese market on March 30, 1995. Eli Lilly and Company's patent for Prozac expired in August of 2001, since then there have appeared a large number of Fluoxetine drugs on the market.
Major Production Enterprises of Fluoxetine in Chinese Market are Patheon France (FR), Shanghai Zhongxi Pharmaceutical Co., Ltd., Shanxi C&Y Pharmaceutical Group Co., Ltd., WATSON Pharmaceuticals (Changzhou) Co., Ltd., Changzhou Siyao Pharmaceutical Co., Ltd., Suzhou Chung-Hwa Pharmaceutical & Chemical Industrial Co., Ltd. (SCCPC)& Eli Lilly and Company. Order a copy of Research Report on Investigation Report on China Fluoxetine Market, 2010-2019 at http://www.reportsnreports.com/Purchase.aspx?name=500794
There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRI's survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%. Eli Lilly and Company (Spain), Eli Lilly and Company (Britain), Patheon (FR), Shanghai Zhongxi Pharmaceutical Co., Ltd, Changzhou Siyao Pharmaceutical Co., Ltd, SCCPC, WATSON Pharmaceuticals (Changzhou) Co., Ltd and Shanxi C&Y Pharmaceutical Group Co., Ltd. occupy large portion in the sales market. Measured by sales value, Lilly (Spain) enjoyed the highest market share, which reached 75% in 2014.
In China, with many people bearing a proliferation of pressure from life, learning and work, the amount of depressive patients will also present an increasing tendency. In conclusion, there exists huge potential in Chinese market demand for Fluoxetine.
Explore more reports on Pharmaceuticals market at
On Simiar lines another research titled Global and Chinese Fluoxetine (CAS 54910-89-3) Industry, 2015 Market Research Report is a professional and in-depth market survey on Global and Chinese Fluoxetine industry. The report firstly reviews the basic information of Fluoxetine including its classification, application and manufacturing technology. The report then explores global and China's top manufacturers of Fluoxetine listing their product specification, capacity, Production value, and market share etc. The report further analyzes quantitatively 2010-2015 global and China's total market of Fluoxetine by calculation of main economic parameters of each company. The breakdown data of Fluoxetine market are presented by company, by country, and by application. The report also estimates 2015-2020 market development of Fluoxetine Industry. The report then analyzes the upstream raw materials, downstream clients, and current market dynamics of Fluoxetine Industry. In the end, the report makes some proposals for a new project of Fluoxetine Industry and a new project of Fluoxetine Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2015 global and China Fluoxetine industry covering all important parameters. Browse complete report at http://www.reportsnreports.com/reports/412683-global-and-chinese-fluoxetine-cas-54910-89-3-industry-2015-market-research-report.html
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts